Bright Green is leveraging automation and technologically driven research & development to cultivate pharmaceutical grade plants, including medical cannabis and marihuana, delivering consistent quality in a state-of-the-art, environmentally controlled, organic ecosystem.
Bright Green Corporation has an agreement with the U.S. Drug Enforcement Administration to construct and operate a federally licensed agricultural center to grow, distribute, and sell medical cannabis, marihuana, or its chemical constituents.
The agreement allows Bright Green to supply certified researchers in the United States and internationally, while also supplying cannabis and derivatives for medical therapies developed from this research.
With our research and development center and affiliations with university research facilities, the New Mexico facility will deliver controlled production 24/7/365. In addition, automation throughout the facility will ensure all reliable processes and product consistency.
Our vision is to improve the quality of life across a broad demographic spectrum through the opportunities presented by medicinal applications of plant-based therapies, particularly cannabis and cannabis-derived products.
Bright Green’s mission is to be the premier federally-authorized provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured in exact formulations for research and pharmaceutical applications and an active ingredient to consumer-based solutions. Through legal partnerships with state and federal agencies, the company can operate at scale in a manner unprecedented in this emerging market, addressing compliance, security, and integrity.